MGX Metagenomi Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$1,02
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,02mínimo 52 semanas
$3,95máximo 52 semanas
Capitalización Bursátil (MRQ)
$39M
P/E
-0.4
BPA
$-2.36
Ingresos
$25M
tus insignias
Rango 52S
$1–$4
Calificación del Analista
BUY
Precio Objetivo
$7
P/E
-0.4
ROE
-49.6%
Margen de Beneficio Neto
-348.5%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
MGX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.02
Capitalización Bursátil (MRQ)
$39M
P/E
-0.4
BPA
$-2.36
Ingresos
$25M
ROE
-49.6%
Rango 52S
$1–$4
MGX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$25M2023-12-31 → 2025-12-31
BPA$-2.362023-12-31 → 2025-12-31
Flujo de caja libre$-89M2024-12-31 → 2025-12-31
Margen neto-348.5%2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | MGX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.4 | · | · | · | |
| P/S | 1.5 | · | · | · | |
| P/C (MRQ) | 0.3 | · | 0.9 | Infravalorado | |
| Precio / FCF (TTM) | -0.4 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -0.5 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.2 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | MGX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -380.9% | · | -639.7% | Débil | |
| EBITDA Margin (Margen EBITDA) | -380.9% | · | -639.7% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -348.8% | · | -558.8% | Débil | |
| Net Profit Margin (Margen de Beneficio Neto) | -348.5% | · | -564.6% | Débil | |
| ROA | -32.2% | · | -47.1% | De primer nivel | |
| ROE | -49.6% | · | -149.4% | De primer nivel | |
| ROIC | -60.5% | · | -159.9% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | MGX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 4.5 | · | 2.6 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 1.8 | · | 1.7 | Por debajo del promedio |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | MGX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -51.8% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | MGX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1 | · | 0.1 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 32.3 | · | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$223.1K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-5.9%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 19, 2026 | $-0.73 | $-0.58 | -26.6% |
| 31 de marzo de 2026 | May 19, 2026 | $-0.61 | $-0.53 | -14.7% |
| 31 de diciembre de 2025 | $-0.60 | $-0.61 | 1.9% | |
| 30 de septiembre de 2025 | $-0.55 | $-0.59 | 6.7% | |
| 30 de junio de 2025 | $-0.54 | $-0.63 | 13.9% | |
| 31 de marzo de 2025 | $-0.68 | $-0.58 | -16.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $52M | $45M | |
| R&D Expense | $94M | $109M | $94M | |
| SG&A Expense | $27M | $32M | $29M | |
| Operating Expenses | $121M | $141M | $123M | |
| Operating Income | $-96M | $-89M | $-78M | |
| Interest Income | $9M | $15M | $15M | |
| Other Non-op | $-91.0K | $-207.0K | $-74.0K | |
| Pretax Income | $-88M | $-84M | $-60M | |
| Income Tax | $-58.0K | $-6M | $8M | |
| Net Income | $-88M | $-78M | $-68M | |
| EPS (Basic) | $-2.36 | $-2.36 | $-20.05 | |
| EPS (Diluted) | $-2.36 | $-2.36 | $-20.05 | |
| Shares (Basic) | 37,251,050 | 33,027,889 | 3,404,585 | |
| Shares (Diluted) | 37,251,050 | 33,027,889 | 3,404,585 | |
| EBITDA | $-96M | $-89M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $42M | $27M | $141M | |
| Receivables | $305.0K | $1M | $2M | |
| Prepaid Expense | $4M | $8M | $5M | |
| Current Assets | $166M | $258M | $278M | |
| PP&E (Net) | $12M | $18M | $22M | |
| PP&E (Gross) | $28M | $29M | $28M | |
| Accum. Depreciation | $16M | $11M | $6M | |
| Other Non-current Assets | $836.0K | $287.0K | $5M | |
| Total Assets | $221M | $325M | $365M | |
| Accounts Payable | $1M | $533.0K | $2M | |
| Current Liabilities | $23M | $37M | $69M | |
| Capital Leases | $35M | $40M | $45M | |
| Other Non-current Liabilities | $2M | $2M | $5M | |
| Total Liabilities | $63M | $90M | $150M | |
| Common Stock | $4.0K | $4.0K | $0 | |
| Paid-in Capital | $469M | $457M | $9M | |
| Retained Earnings | $-311M | $-223M | $-145M | |
| AOCI | $260.0K | $709.0K | $-97.0K | |
| Stockholders' Equity | $159M | $235M | $-136M | |
| Liabilities + Equity | $221M | $325M | $365M | |
| Shares Outstanding | 37,620,668 | 37,418,470 | 3,404,585 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $12M | $16M | $7M | |
| Operating Cash Flow | $-89M | $-109M | $-91M | |
| CapEx | $574.0K | $3M | $10M | |
| Investing Cash Flow | $104M | $-88M | $46M | |
| Financing Cash Flow | $-356.0K | $84M | $1M | |
| Net Change in Cash | $14M | $-113M | $-45M | |
| Taxes Paid | $-2M | $4M | $2M | |
| Free Cash Flow | $-89M | $-112M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -380.9% | -170.0% | · | |
| Net Margin | -348.5% | -149.3% | · | |
| Pretax Margin | -348.8% | -159.8% | · | |
| EBITDA Margin | -380.9% | -170.0% | · | |
| ROA | -32.2% | -22.6% | · | |
| ROE | -49.6% | -31.8% | · | |
| ROIC | -60.5% | -35.4% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.2 | 6.9 | · | |
| Quick Ratio | 1.8 | 0.8 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | |
| Receivables Turnover | 32.3 | 28.2 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $4.22 | $6.28 | · | |
| Revenue / Share | $0.68 | $1.58 | · | |
| Cash Flow / Share | $-2.39 | $-3.30 | · | |
| Cash / Share | $1.11 | $0.73 | · | |
| EPS (TTM) | $-2.36 | $-2.36 | $-20.05 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -51.8% | 16.8% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $52M | $45M | |
| Net Income TTM | $-88M | $-78M | $-68M | |
| Market Cap | $61M | $135M | · | |
| P/E | -0.7 | -1.5 | · | |
| P/S | 2.4 | 2.6 | · | |
| P/B | 0.4 | 0.6 | · | |
| P / Tangible Book | 0.4 | 0.6 | · | |
| P / Cash Flow | -0.7 | -1.2 | · | |
| P / FCF | -0.7 | -1.2 | · | |
| Earnings Yield | -145.7% | -65.4% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $1M | $4M | $9M | $9M | $4M | $10M | $12M | $20M | $11M | $12M | $12M | $11M | $9M | |
| R&D Expense | $23M | $19M | $22M | $25M | $23M | $25M | $23M | $26M | $28M | $31M | $25M | $27M | $23M | $20M | |
| SG&A Expense | $6M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $9M | $9M | $8M | $8M | $7M | $6M | |
| Operating Expenses | $29M | $26M | $28M | $31M | $30M | $32M | $30M | $34M | $37M | $40M | $33M | $35M | $29M | $27M | |
| Operating Income | $-29M | $-25M | $-24M | $-23M | $-21M | $-28M | $-21M | $-22M | $-17M | $-29M | $-20M | $-22M | $-18M | $-18M | |
| Interest Income | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-op | $35.0K | $-1.0K | $-11.0K | $-2.0K | $-70.0K | $-8.0K | $-49.0K | $-57.0K | $-51.0K | $-50.0K | $-4.0K | $-85.0K | $16.0K | $-1.0K | |
| Pretax Income | $-27M | $-23M | $-22M | $-21M | $-20M | $-25M | $-25M | $-21M | $-13M | $-25M | $-17M | $-19M | $-11M | $-14M | |
| Income Tax | $0 | $10.0K | $34.0K | $-234.0K | $44.0K | $98.0K | $-1M | $-2M | $-2M | $0 | $7M | $1M | $2M | $-2M | |
| Net Income | $-27M | $-23M | $-23M | $-20M | $-20M | $-25M | $-23M | $-19M | $-11M | $-25M | $-19M | $-20M | $-13M | $-16M | |
| EPS (Basic) | $-0.73 | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| EPS (Diluted) | $-0.73 | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| Shares (Basic) | 37,658,250 | 37,581,094 | · | 37,349,449 | 37,156,979 | 37,019,027 | · | 36,766,309 | 36,625,291 | 21,137,868 | · | 3,404,585 | 3,404,585 | 3,404,585 | |
| Shares (Diluted) | 37,658,250 | 37,581,094 | · | 37,349,449 | 37,156,979 | 37,019,027 | · | 36,766,309 | 36,625,291 | 21,137,868 | · | 3,404,585 | 3,404,585 | 3,404,585 | |
| EBITDA | $-29M | $-25M | · | $-23M | $-21M | $-28M | · | $-22M | $-17M | $-29M | · | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $25M | $42M | $33M | $27M | $29M | $27M | $25M | $61M | $103M | $141M | · | · | · | |
| Receivables | $0 | $0 | $305.0K | $960.0K | $900.0K | $900.0K | $1M | $589.0K | $2M | $2M | $2M | · | · | · | |
| Prepaid Expense | $4M | $4M | $4M | $5M | $6M | $6M | $8M | $7M | $6M | $6M | $5M | · | · | · | |
| Current Assets | $124M | $145M | $166M | $190M | $212M | $233M | $258M | $282M | $308M | $336M | $278M | · | · | · | |
| PP&E (Net) | $10M | $11M | $12M | $14M | $15M | $17M | $18M | $20M | $21M | $21M | $22M | · | · | · | |
| PP&E (Gross) | · | · | $28M | · | · | · | $29M | · | · | · | $28M | · | · | · | |
| Accum. Depreciation | · | · | $16M | · | · | · | $11M | · | · | · | $6M | · | · | · | |
| Other Non-current Assets | $1M | $927.0K | $836.0K | $809.0K | $805.0K | $781.0K | $287.0K | $320.0K | $332.0K | $379.0K | $5M | · | · | · | |
| Total Assets | $174M | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Accounts Payable | $3M | $2M | $1M | $1M | $3M | $3M | $533.0K | $3M | $3M | $7M | $2M | · | · | · | |
| Current Liabilities | $28M | $22M | $23M | $30M | $33M | $40M | $37M | $46M | $53M | $71M | $69M | · | · | · | |
| Capital Leases | $31M | $33M | $35M | $36M | $37M | $39M | $40M | $41M | $43M | $44M | $45M | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | · | · | · | |
| Total Liabilities | $61M | $59M | $63M | $69M | $76M | $85M | $90M | $103M | $116M | $140M | $150M | · | · | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $0 | · | · | · | |
| Paid-in Capital | $474M | $472M | $469M | $466M | $463M | $460M | $457M | $454M | $451M | $446M | $9M | · | · | · | |
| Retained Earnings | $-361M | $-334M | $-311M | $-288M | $-268M | $-248M | $-223M | $-200M | $-181M | $-170M | $-145M | · | · | · | |
| AOCI | $-122.0K | $-44.0K | $260.0K | $371.0K | $372.0K | $621.0K | $709.0K | $2M | $-265.0K | $-278.0K | $-97.0K | · | · | · | |
| Stockholders' Equity | $113M | $138M | $159M | $178M | $196M | $213M | $235M | $256M | $269M | $276M | $-136M | · | · | · | |
| Liabilities + Equity | $174M | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Shares Outstanding | 37,777,105 | 37,647,057 | 37,620,668 | 37,546,751 | 37,533,136 | 37,382,478 | 37,418,470 | 37,432,832 | 37,459,853 | 37,468,078 | 3,404,585 | · | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $2M | $3M | $656.0K | $529.0K | |
| Operating Cash Flow | $-20M | $-21M | $-24M | $-21M | $-21M | $-23M | $-26M | $-27M | $-26M | $-30M | $-21M | $-24M | $-26M | $-21M | |
| CapEx | $125.0K | $25.0K | $85.0K | $74.0K | $127.0K | $288.0K | $334.0K | $1M | $665.0K | $915.0K | $2M | $2M | $3M | $3M | |
| Investing Cash Flow | $33M | $4M | $32M | $27M | $19M | $25M | $29M | $-9M | $-13M | $-95M | $61M | $76M | $-19M | $-72M | |
| Financing Cash Flow | $67.0K | $-27.0K | $74.0K | $-187.0K | $-166.0K | $-77.0K | $0 | $-492.0K | $-2M | $87M | $-1M | $-2M | $-39.0K | $4M | |
| Net Change in Cash | $14M | $-17M | $9M | $6M | $-2M | $2M | $2M | $-36M | $-41M | $-38M | $39M | $50M | $-45M | $-89M | |
| Free Cash Flow | · | $-21M | · | · | · | $-23M | · | · | · | $-31M | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| Net Margin | · | -1847.7% | · | -235.5% | -233.8% | -606.7% | · | -163.0% | -53.7% | -225.4% | · | · | · | · | |
| Pretax Margin | · | -1846.9% | · | -238.2% | -233.3% | -604.3% | · | -181.3% | -64.7% | -225.4% | · | · | · | · | |
| EBITDA Margin | · | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| ROA | -12.3% | -9.3% | · | -6.7% | -6.0% | -7.0% | · | -10.5% | -5.6% | -12.1% | · | · | · | · | |
| ROE | -17.8% | -13.2% | · | -9.4% | -8.6% | -10.3% | · | -14.7% | -8.0% | -18.2% | · | · | · | · | |
| ROIC | -25.6% | -17.8% | · | -12.7% | -10.7% | -13.1% | · | -7.9% | -5.2% | -10.5% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.4 | · | 6.4 | 6.4 | 5.8 | · | 6.2 | 5.8 | 4.7 | · | · | · | · | |
| Quick Ratio | 1.4 | 1.1 | · | 1.1 | 0.8 | 0.8 | · | 0.6 | 1.2 | 1.5 | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Receivables Turnover | · | 2.8 | · | 11.2 | 6.7 | 2.8 | · | 39.1 | 24.3 | 10.7 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.98 | $3.66 | · | $4.75 | $5.22 | $5.69 | · | $6.83 | $7.19 | $7.36 | · | · | · | · | |
| Revenue / Share | · | $0.03 | · | $0.23 | $0.23 | $0.11 | · | $0.31 | $0.55 | $0.53 | · | · | · | · | |
| Cash Flow / Share | · | $-0.56 | · | · | · | $-0.62 | · | · | · | $-1.41 | · | · | · | · | |
| Cash / Share | $1.03 | $0.67 | · | $0.87 | $0.72 | $0.78 | · | $0.67 | $1.63 | $2.74 | · | · | · | · | |
| EPS (TTM) | $-2.48 | $-2.29 | · | $-2.14 | $-2.10 | $-1.85 | · | $-7.66 | $-12.97 | $-16.50 | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $22M | · | $31M | $34M | $45M | · | $55M | $56M | $47M | · | · | · | · | |
| Net Income TTM | $-93M | $-86M | · | $-89M | $-87M | $-78M | · | $-74M | $-75M | $-77M | · | · | · | · | |
| Market Cap | $45M | $50M | · | $89M | $56M | $51M | · | $81M | $153M | $395M | · | · | · | · | |
| P/E | -0.5 | -0.6 | · | -1.1 | -0.7 | -0.7 | · | -0.3 | -0.3 | -0.6 | · | · | · | · | |
| P/S | 2.0 | 2.3 | · | 2.9 | 1.6 | 1.1 | · | 1.5 | 2.7 | 8.4 | · | · | · | · | |
| P/B | 0.4 | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Tangible Book | 0.4 | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Cash Flow | · | -2.4 | · | · | · | -2.2 | · | · | · | -13.2 | · | · | · | · | |
| Earnings Yield | -208.4% | -170.9% | · | -90.3% | -141.9% | -136.0% | · | -353.0% | -317.9% | -156.4% | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Ingresos | $25M | $52M | $45M |
| Margen Operativo % | -380.9% | -170.0% | · |
| Beneficio neto | $-88M | $-78M | $-68M |
| EPS Diluido | $-2.36 | $-2.36 | $-20.05 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Ratio corriente | 7.2 | 6.9 | · |
| Ratio Rápido | 1.8 | 0.8 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Flujo de caja libre | $-89M | $-112M | · |
Propietarios institucionales (13F) 51 declarantes · $11.5M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
51
Valor en tenencia
$11.5M
Nuevas posiciones
4
Posiciones cerradas
8
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 4 (-1 vs trimestre anterior) | 8 (-3 vs trimestre anterior) | 12 (+2 vs trimestre anterior) | 13 (-2 vs trimestre anterior) | -201K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2 057 799 | 1 270 246 | 17,90% | Acciones |
| Sozo Ventures GP II, L.P. | $1 331 404 | 581 577 | 11,58% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 282 463 | 1 077 700 | 11,16% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $883 456 | 742 400 | 7,69% | Acciones |
| Catalio Capital Management, LP | $629 502 | 528 993 | 5,48% | Acciones |
| Peapod Lane Capital LLC | $624 779 | 525 024 | 5,44% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $611 304 | 513 701 | 5,32% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $476 357 | 400 300 | 4,14% | Acciones |
| WELLS FARGO & COMPANY/MN | $451 614 | 379 508 | 3,93% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $343 672 | 288 665 | 2,99% | Acciones |
| TWO SIGMA ADVISERS, LP | $326 106 | 201 300 | 2,84% | Acciones |
| PURA VIDA INVESTMENTS, LLC | $314 625 | 264 391 | 2,74% | Acciones |
| BlackRock, Inc. | $306 581 | 257 631 | 2,67% | Acciones |
| Good Life Advisors, LLC | $296 000 | 200 000 | 2,58% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $203 789 | 171 251 | 1,77% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $190 400 | 160 000 | 1,66% | Acciones |
| STATE STREET CORP | $142 622 | 119 850 | 1,24% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $135 690 | 114 025 | 1,18% | Acciones |
| Man Group plc | $129 865 | 109 130 | 1,13% | Acciones |
| Resolute Advisors LLC | $107 033 | 89 944 | 0,93% | Acciones |
| Marquette Asset Management, LLC | $85 824 | 72 121 | 0,75% | Acciones |
| NORTHERN TRUST CORP | $82 036 | 68 938 | 0,71% | Acciones |
| RBF Capital, LLC | $76 185 | 64 021 | 0,66% | Acciones |
| XTX Topco Ltd | $66 291 | 55 707 | 0,58% | Acciones |
| BBR PARTNERS, LLC | $63 550 | 53 403 | 0,55% | Acciones |
| JANE STREET GROUP, LLC | $45 691 | 38 396 | 0,40% | Acciones |
| Fortitude Advisory Group L.L.C. | $44 256 | 37 190 | 0,39% | Acciones |
| CITADEL ADVISORS LLC | $21 243 | 17 851 | 0,18% | Acciones |
| Qube Research & Technologies Ltd | $20 052 | 16 850 | 0,17% | Acciones |
| UBS Group AG | $18 794 | 15 793 | 0,16% | Acciones |
| TWO SIGMA SECURITIES, LLC | $18 056 | 15 173 | 0,16% | Acciones |
| Cubist Systematic Strategies, LLC | $17 682 | 7 461 | 0,15% | Acciones |
| Vanguard Global Advisers, LLC | $15 936 | 13 392 | 0,14% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $15 228 | 12 797 | 0,13% | Acciones |
| Peak Planning Group, LLC | $14 875 | 12 500 | 0,13% | Acciones |
| Point72 Asia (Singapore) Pte. Ltd. | $11 665 | 4 922 | 0,10% | Acciones |
| MEEDER ASSET MANAGEMENT INC | $6 540 | 5 496 | 0,06% | Acciones |
| MORGAN STANLEY | $6 309 | 5 302 | 0,05% | Acciones |
| Tower Research Capital LLC (TRC) | $6 307 | 5 300 | 0,05% | Acciones |
| US BANCORP \DE\ | $5 355 | 4 500 | 0,05% | Acciones |
| OSAIC HOLDINGS, INC. | $2 250 | 1 891 | 0,02% | Acciones |
| JPMORGAN CHASE & CO | $1 915 | 1 596 | 0,02% | Acciones |
| FMR LLC | $700 | 588 | 0,01% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $625 | 500 | 0,01% | Acciones |
| Allworth Financial LP | $595 | 500 | 0,01% | Acciones |
| Point72 (DIFC) Ltd | $318 | 134 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $246 | 207 | 0,00% | Acciones |
| BARCLAYS PLC | $199 | 167 | 0,00% | Acciones |
| CWM, LLC | $34 | 25 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $10 | 8 | 0,00% | Acciones |
Informantes de la empresa 14 insiders · 7 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jian Irish | President and Chief Executive Officer | 8 de septiembre de 2026 S | 375 393 | 0 | 5 | $-15 647 |
| Pamela Wapnick | Chief Financial Officer | 8 de septiembre de 2026 S | 206 580 | 0 | 5 | $-14 139 |
| Matthew Wein | Title: General Counsel, Compliance Officer and Corporate Secretary | 8 de septiembre de 2026 S | 126 133 | 0 | 5 | $-2 623 |
| Sarah B. Noonberg | Chief Medical Officer | 6 de junio de 2025 S | 109 135 | 0 | 0 | $0 |
| Simren Delaney | Title: Vice President of Intellectual Property and Legal Operations | 1 de abril de 2024 A | 93 892 | 0 | 0 | $0 |
| Simon Harnest | Title: Chief Investment Officer and Senior Vice President of Strategy | 1 de abril de 2024 A | 122 664 | 0 | 0 | $0 |
| Luis Borges | Chief Scientific Officer | 1 de abril de 2024 A | 69 316 | 0 | 0 | $0 |
| Laurence Reid | Consejero | 9 de septiembre de 2026 P | 20 000 | 2 | 0 | $23 401 |
| Juergen Eckhardt | Consejero | 9 de junio de 2026 A | · | 0 | 0 | $0 |
| Willard H Dere | Consejero | 9 de junio de 2026 A | · | 0 | 0 | $0 |
| Eric Bjerkholt | Consejero | 9 de junio de 2026 A | · | 0 | 0 | $0 |
| Brian C. Thomas | Consejero | 5 de diciembre de 2025 S | 2 510 960 | 0 | 2 | $-11 668 |
| Sebastian Bernales | Consejero | 1 de abril de 2024 A | 1 896 445 | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 13 de febrero de 2024 C | 1 739 175 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| ISCF · iShares Trust | 0,07% | 1 807 801 SH | 11 de septiembre de 2026 | Diario |
| IWC · iShares Trust | 0,01% | 94 851 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 315 460 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 741 407 SH | 19 de agosto de 2026 | Diario |
MGX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 9 analistas
COMPRA
Objetivo mediano
$7.00
+586,3%
2 22,2%
Compra fuerte
5 55,6%
Compra
2 22,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-10-03Objetivo medio $7.00 +586,3%
← Por Debajo de Todos los Objetivos
Precio Actual $1.02
Mín$5.00
Media$7.00
Máx$9.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | · |
| HOWL | $31M | -0.5 | · | · | -183.6% | · |
| TVGN | · | · | · | · | · | · |
| LITS | $30M | -0.4 | 33.8% | · | -115.3% | · |
| PDSB | · | -1.0 | · | · | · | · |
| ELUT | · | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026